BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9408753)

  • 1. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.
    Bärlund M; Tirkkonen M; Forozan F; Tanner MM; Kallioniemi O; Kallioniemi A
    Genes Chromosomes Cancer; 1997 Dec; 20(4):372-6. PubMed ID: 9408753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
    Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
    Oncogene; 1999 Nov; 18(46):6262-70. PubMed ID: 10597224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
    Forozan F; Mahlamäki EH; Monni O; Chen Y; Veldman R; Jiang Y; Gooden GC; Ethier SP; Kallioniemi A; Kallioniemi OP
    Cancer Res; 2000 Aug; 60(16):4519-25. PubMed ID: 10969801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
    Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
    Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
    Coene ED; Schelfhout V; Winkler RA; Schelfhout AM; Van Roy N; Grooteclaes M; Speleman F; De Potter CR
    Virchows Arch; 1997 May; 430(5):365-72. PubMed ID: 9174626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
    Bärlund M; Forozan F; Kononen J; Bubendorf L; Chen Y; Bittner ML; Torhorst J; Haas P; Bucher C; Sauter G; Kallioniemi OP; Kallioniemi A
    J Natl Cancer Inst; 2000 Aug; 92(15):1252-9. PubMed ID: 10922410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations in ERBB2-amplified breast carcinomas.
    Isola J; Chu L; DeVries S; Matsumura K; Chew K; Ljung BM; Waldman FM
    Clin Cancer Res; 1999 Dec; 5(12):4140-5. PubMed ID: 10632352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas.
    Latham C; Zhang A; Nalbanti A; Månér S; Zickert P; Blegen H; Zetterberg A
    Cancer Genet Cytogenet; 2001 May; 127(1):16-23. PubMed ID: 11408059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.
    Kallioniemi A; Kallioniemi OP; Piper J; Tanner M; Stokke T; Chen L; Smith HS; Pinkel D; Gray JW; Waldman FM
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2156-60. PubMed ID: 8134364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.
    Vidgren V; Varis A; Kokkola A; Monni O; Puolakkainen P; Nordling S; Forozan F; Kallioniemi A; Vakkari ML; Kivilaakso E; Knuutila S
    Genes Chromosomes Cancer; 1999 Jan; 24(1):24-9. PubMed ID: 9892105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.
    Storlazzi CT; Brekke HR; Mandahl N; Brosjö O; Smeland S; Lothe RA; Mertens F
    J Pathol; 2006 Aug; 209(4):492-500. PubMed ID: 16721726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
    Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
    Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of DNA copy-number changes using cDNA microarrays.
    Pollack JR; Perou CM; Alizadeh AA; Eisen MB; Pergamenschikov A; Williams CF; Jeffrey SS; Botstein D; Brown PO
    Nat Genet; 1999 Sep; 23(1):41-6. PubMed ID: 10471496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis.
    Marchiò C; Lambros MB; Gugliotta P; Di Cantogno LV; Botta C; Pasini B; Tan DS; Mackay A; Fenwick K; Tamber N; Bussolati G; Ashworth A; Reis-Filho JS; Sapino A
    J Pathol; 2009 Sep; 219(1):16-24. PubMed ID: 19670217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.